Back to Search
MARK EAGLETON, M.D., M.P.H.
M.D., M.P.H.
Anesthesiology Physician
NPI: 1306281621IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
270562(MA)S3898(TX)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 2013
Research & Publications (20)
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.
PMID 19442620·Bone·2009
7-preclinical
Late complications after endovascular thoracoabdominal aneurysm repair.
PMID 19573747·Semin Vasc Surg·2009
6-review
Endovascular management of chronic infrarenal aortic occlusion.
PMID 19281286·J Endovasc Ther·2009
8-other
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.
PMID 19059914·J Biol Chem·2009
7-preclinical
Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia.
PMID 18295100·J Vasc Surg·2008
8-other
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
PMID 18260128·J Cell Biochem·2008
7-preclinical
Angiography underestimates peripheral atherosclerosis: lumenography revisited.
PMID 18254670·J Endovasc Ther·2008
8-other
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone.
PMID 17715292·Proc Natl Acad Sci U S A·2007
7-preclinical
Molecular diagnoses and treatments--past, present, or future?
PMID 17580251·Semin Vasc Surg·2007
6-review
Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner.
PMID 17192391·Blood·2007
7-preclinical
The nitric oxide donor DETA-NONOate decreases matrix metalloproteinase-9 expression and activity in rat aortic smooth muscle and abdominal aortic explants.
PMID 16378139·Ann Vasc Surg·2006
7-preclinical
The management of trauma venous injury: civilian and wartime experiences.
PMID 17060235·Perspect Vasc Surg Endovasc Ther·2006
6-review
Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation.
PMID 16716358·J Surg Res·2006
4-observational
A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2.
PMID 16476613·J Vasc Surg·2006
8-other
Alterations in angiotensin converting enzyme during rodent aortic aneurysm formation.
PMID 16325859·J Surg Res·2006
7-preclinical
L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation.
PMID 15998669·Circulation·2005
7-preclinical
Mitochondrial-dependent apoptosis in experimental rodent abdominal aortic aneurysms.
PMID 16269312·Surgery·2005
7-preclinical
Gender differences in rat aortic smooth muscle cell matrix metalloproteinase-9.
PMID 16125073·J Am Coll Surg·2005
7-preclinical
Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms.
PMID 15696052·J Vasc Surg·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 Boston Medical Ctr Pl
Boston, MA 02118 - Phone
- (617) 638-6975
Quick Facts
- NPI
- 1306281621
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile